Major liver resection in elderly patients: A multi-institutional analysis

Journal of the American College of Surgeons

Volumn 212, Issue 5, 2011, Pages 787-795

  Reddy, Srinevas K ^a,b   Barbas, Andrew S ^a   Turley, Ryan S ^a   Gamblin, T Clark ^c   Geller, David A ^b   Marsh, J Wallis ^b   Tsung, Allan ^b   Clary, Bryan M ^a   Lagoo Deenadayalan, Sandhya ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BILIRUBIN;

ABSCESS; ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; BILE DUCT CARCINOMA; BILE LEAKAGE; BILIRUBIN BLOOD LEVEL; BLEEDING; BRAIN DISEASE; CEREBROVASCULAR ACCIDENT; CHOLANGITIS; COLORECTAL CANCER; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DELIRIUM; DEMOGRAPHY; DISEASE ASSOCIATION; ELECTIVE SURGERY; ERYTHROCYTE TRANSFUSION; FASCIA DISEASE; FEMALE; GERIATRIC SURGERY; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; KIDNEY FAILURE; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER RESECTION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PEROPERATIVE CARE; PNEUMONIA; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SEPSIS; SEX DIFFERENCE; SURGICAL MORTALITY; SURGICAL PATIENT; WOUND DEHISCENCE; WOUND INFECTION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; NORTH CAROLINA; PENNSYLVANIA; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 79955579965     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2010.12.048     Document Type: Article

References (41)

1. Petrowsky H, Clavien PA. Should we deny surgery fo rmalignant hepato-pancreatico-biliary tumors?World J Surg 2005;29: 1093-1100.
2. Smith BD, Smith GL, Hurria A, et al. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 2009;27:2758-2765.
3. Mirici-Cappa F, Gramenzi A, Santi V, et al. Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience. Gut 2010; 59:387-396.
4. Asahina Y, Tsuchia K, Tamaki N, et al. Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection. Hepatology 2010;52:518-527.
5. Pasetto LM, Lise M, Monfardini S. Preoperative assessment of elderly cancer patients. Crit Rev Oncol/Hematol 2007;64: 10-18. (Pubitemid 47371206)
6. Schmucker DL. Age-related changes in liver structure and function: implications for disease? Exp Gerontol 2005;40:650-659.
7. Monson K, Litvak DA, Bold RJ. Surgery in the aged population: surgical oncology. Arch Surg 2003;138:1061-1067. (Pubitemid 37238589)
8. Neugut AI, Fleischauer AT, Sundararajan V, et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol 2002;20:2643-2650. (Pubitemid 34575636)
9. Yee KWL, Pater JL, Pho L, et al. Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier? J Clin Oncol 2003;21:1618-1623. (Pubitemid 46594117)
10. Jessup JM, Stewart A, Greene FL, Minsky BD. Adjuvant chemotherapy for stage III colon cancer: implications of race/ ethnicity, age, and differentiation. JAMA 2005;294:2703-2711. (Pubitemid 41770099)
11. Hutchins LF, Unger JM, Crowley JJ, et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999;341:2061-2067. (Pubitemid 30035956)
12. Unger JM, Coleman CA, Crowley JJ, et al. Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials. J Clin Oncol 2006;24:141-144.
13. Kahn KL, Adams JL, Weeks JC, et al. Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA 2010;303:1037-1045.
14. Ychou M, Hohenberger W, Thezenas S, et al. A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer. Ann Oncol 2009;20:1964-1970.
15. Kanemitsu Y, Kato T, Shimizu Y, et al. A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone as treatment for liver metastasis from colorectal cancer: Japan Clinical Oncology Group JCOG0603. Jpn J Clin Oncol 2009;39:406-409.
16. Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomized controlled trial. Lancet 2008;371:1007-1016. (Pubitemid 351392040)
17. Portier G, Elias D, Bouche O, et al. Multicenter randomized controlled trial of adjuvant fluorouracil and folinic compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol 2006;31: 4976-4982. (Pubitemid 46631399)
18. Kemeny NE, Niedzwiecki D, Hollis DR, et al. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 2006;24: 1394-1403.
19. Kemeny MM, Adak S, Gray B, et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy - an intergroup study. J Clin Oncol 2002;20:1499-1505. (Pubitemid 34260528)
20. Okusaka T, Kasugai H, Shioyama Y, et al. Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: a randomized phase III trial. J Hepatol 2009;51:1030-1036.
21. Zhong C, Guo RP, Li JQ, et al. A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage IIIA hepatocellular carcinoma. J Cancer Res Clin Oncol 2009;135:1437-1445.
22. Zhou WP, Lai EC, Li AJ, et al. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg 2009; 249:195-202.
23. Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomized, doubleblind, placebo-controlled trial. Lancet Oncol 2009;10:25-34.
24. Llovet JM, Ricci S, Mazzaferro V, et al. SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359:378-390.
25. Lau WY, Lai EC, Leung TW, Yu SC. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival. Ann Surg 2008;247:43-48.
26. Manfredi S, Lepage C, Hatem C, et al. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 2006;244:254-259. (Pubitemid 44305540)
27. Leporrier J, Maurel J, Chiche L, et al. A population-based study of the incidence, management, and prognosis of hepatic metastases from colorectal cancer. Br J Surg 2006;93:465-474.
28. Fong Y, Brennan MF, Cohen AM, et al. Liver resection in the elderly. Br J Surg 1997;84:1386-1390. (Pubitemid 27443441)
29. Cescon M, Grazi GL, Del Gaudio M, et al. Outcome of right hepatectomies in patients older than 70 years. Arch Surg 2003; 138:547-552. (Pubitemid 36542472)
30. Ettorre GM, Sommacale D, Farges O, et al. Postoperative liver function after elective right hepatectomy in elderly patients. Br J Surg 2001;88:73-76. (Pubitemid 32066061)
31. Aldrighetti L, Arru M, Calori G, et al. Impact of age on the outcome of liver resections. Am Surg 2004;70:453-460.
32. Shirabe K, Kajiyama K, Harimoto N, et al. Early outcome following hepatic resection in patients older than 80 years of age. World J Surg 2009;33:1927-1932.
33. Adam R, Frilling A, Elias D, et al. Liver resection of colorectal metastases in elderly patients. Br J Surg 2010;97:366-376.
34. Koperna T, Kisser M, Schulz F. Hepatic resection in the elderly. World J Surg 1998;22:406-412. (Pubitemid 28113530)
35. Menon KV, Al-Mukhtar A, Aldouri A, et al. Outcomes after major hepatectomy in elderly patients. J Am Coll Surg 2006; 203:677-683. (Pubitemid 44648785)
36. Kristjansson SR, Nesbakken A, Jordhoy MS, et al. Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: a prospective observational cohort study. Crit Rev Oncol/Hematol 2010;76: 208-217.
37. Christmas C, Makary MA, Burton JR. Medical considerations in older surgical patients. J Am Coll Surg 2006;203: 746-751. (Pubitemid 44648796)
38. Fukuse T, Satoda N, Hijiya K, Fujinaga T. Importance of a comprehensive geriatric assessment in prediction of complications following thoracic surgery in elderly patients. Chest 2005; 127:886-891. (Pubitemid 40775520)
39. PACE participants. Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help A SIOG surgical task force prospective study. Crit Rev Oncol/Hematol 2008;65:156-163.
40. Dindo D, DeMartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213. (Pubitemid 38963009)
41. Strasberg SM, Linehan DC, Hawkins WG. The accordion severity grading system of surgical complications. Ann Surg 2009; 250:177-186.